These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24272769)

  • 1. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review.
    Cardellicchio S; Bacci G; Farina S; Genitori L; Massimino M; de Martino M; Caputo R; Sardi I
    Neuropediatrics; 2014 Feb; 45(1):42-9. PubMed ID: 24272769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
    Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M
    No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP; Leary S; Khanna P; Weiss AH
    Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma.
    Massimino M; Spreafico F; Cefalo G; Riccardi R; Tesoro-Tess JD; Gandola L; Riva D; Ruggiero A; Valentini L; Mazza E; Genitori L; Di Rocco C; Navarria P; Casanova M; Ferrari A; Luksch R; Terenziani M; Balestrini MR; Colosimo C; Fossati-Bellani F
    J Clin Oncol; 2002 Oct; 20(20):4209-16. PubMed ID: 12377964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma.
    Massimino M; Spreafico F; Riva D; Biassoni V; Poggi G; Solero C; Gandola L; Genitori L; Modena P; Simonetti F; Potepan P; Casanova M; Meazza C; Clerici CA; Catania S; Sardi I; Giangaspero F
    J Neurooncol; 2010 Oct; 100(1):65-71. PubMed ID: 20151174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
    Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optic glioma in children: a retrospective analysis of 101 cases.
    Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcome following chemotherapy for progressive optic pathway gliomas.
    Shofty B; Ben-Sira L; Freedman S; Yalon M; Dvir R; Weintraub M; Toledano H; Constantini S; Kesler A
    Pediatr Blood Cancer; 2011 Sep; 57(3):481-5. PubMed ID: 21241008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT; Cmelak A; Johnson MD; Moots PL; Pais R; Shyr Y
    Pediatr Blood Cancer; 2004 Jul; 43(1):46-54. PubMed ID: 15170889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
    Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
    Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
    Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
    Peckham MJ; Horwich A; Blackmore C; Hendry WF
    Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refining therapeutic strategies for patients with resistant Wilm's tumor.
    Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Gershenson DM; Morris M; Burke TW; Levenback C; Matthews CM; Wharton JT
    Obstet Gynecol; 1996 Apr; 87(4):527-31. PubMed ID: 8602303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of optic pathway hypothalamic gliomas in childhood: experience with 18 consecutive cases.
    Jaing TH; Lin KL; Tsay PK; Hsueh C; Hung PC; Wu CT; Tseng CK
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):222-4. PubMed ID: 18376285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history and outcome of optic pathway gliomas in children.
    Nicolin G; Parkin P; Mabbott D; Hargrave D; Bartels U; Tabori U; Rutka J; Buncic JR; Bouffet E
    Pediatr Blood Cancer; 2009 Dec; 53(7):1231-7. PubMed ID: 19621457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.